Hawkmont Research | Equity Research | AI Hardware & Semiconductors May 7, 2026 | INITIATING COVERAGE This report is produced independently by Hawkmont Research. No compensation was received from any company mentioned herein. All prices and market data as of May 7, 2026 unless otherwise noted. This is not investment advice. Please read full disclosures at the end of this report. Which Stocks Benefit from the AI Glasses Build-Out? The short answer: not the ones absorbing most o

Hawkmont Research | Equity Research | Digital Payments & Fintech April 22, 2026 | INITIATING COVERAGE This report is produced independently by Hawkmont Research. No compensation was received from any company mentioned herein. All prices and market data as of April 22, 2026 unless otherwise noted. This is not investment advice. Please read full disclosures at the end of this report. PayPal Holdings, Inc. (NASDAQ: PYPL) | Rating: SELL | Price Target: $35.00 | Current Price: $48

Hawkmont Research | Equity Research | Space Economy April 13, 2026 | INITIATING COVERAGE This report is produced independently by Hawkmont Research. No compensation was received from any company mentioned herein. All prices and market data as of April 13, 2026 unless otherwise noted. This is not investment advice. Please read full disclosures at the end of this report. The SpaceX Launch Complex at launch pad 39-A at the Kennedy Space Center in Cape Canaveral, Florida, US., A

Hawkmont Research | Biotechnology | Cell Therapy | Clinical-Stage Equities April 13, 2026 EXECUTIVE SUMMARY Allogene Therapeutics (Nasdaq: ALLO) is the last independent, publicly traded pure-play allogeneic CAR T company of scale. This morning, on April 13, 2026, the company released interim futility analysis data from its pivotal Phase 2 ALPHA3 trial in first-line large B-cell lymphoma. Cema-cel achieved 58.3% MRD negativity at Day 45 versus 16.7% in the observation arm, a 4

Macro Strategy | Geopolitical Finance Classification: Institutional Distribution Only | April 2026 Research Coverage: Global Macro / Geopolitical Finance / Reserve Currency Strategy Distribution: Macro Portfolio Managers, EM Specialists, Fixed Income Strategy, Commodities Desks This report reflects analysis as of April 2026. Data is sourced from IMF COFER, SWIFT RMB Tracker, World Gold Council, PBOC, BIS, New Development Bank disclosures, and publicly available BRICS summi

HAWKMONT RESEARCH | Currency Markets & Global Macro Strategy Publication Date: April 2, 2026 | Report Code: HMR-FX-2026-Q2-CHF For Institutional and Professional Clients Only Executive Summary Thesis: The Swiss franc has not merely reclaimed its safe-haven mantle. It has strengthened its claim as the world's premier flight-to-safety currency. As of April 2, 2026, the CHF has appreciated 3.5% against the U.S. dollar year-to-date, building on a 12.7% gain in 2025, which includ

Initiating Coverage | Hawkmont Research | April 2026 HAWKMONT RESEARCH | EQUITY RESEARCH | NATIONAL SECURITY SPACE The most important satellite manufacturing program in U.S. defense history has one company that has won every tranche. That company just went public at $34 and trades at $22. Rating: Neutral (Hold) | Price Target: $28 | Current Price: ~$22 | Ticker: NYSE: YSS Investment Thesis York Space Systems is the dominant prime contractor for the Space Development Agency's

The Most Significant Supply Disruption Since 1973. Here Is What It Means for Your Portfolio. Hawkmont Research | Energy Geopolitics | Macro | Commodities EXECUTIVE SUMMARY Iran's Islamic Revolutionary Guard Corps has imposed a de facto naval blockade on the Strait of Hormuz since March 3, 2026, reducing commercial transits from a normal daily average of 130 to 150 vessels to just 7 as of March 29. That single fact has already sent Brent crude from $86 to $138.40, a 61% spike

Initiating Coverage | Hawkmont Research | March 2026 Investment Thesis ZenaTech (ZENA) presents a rare structure in the small-cap defense universe: a self-funding DaaS rollup that generates real and growing revenue today, while simultaneously incubating a portfolio of autonomous drone and counter-UAS platforms that address one of the most urgent capability gaps in modern defense. We initiate coverage with a Speculative Buy rating and a 12-to-18 month price target of $7.00, re

March 26, 2026 HAWKMONT RESEARCH | EQUITY RESEARCH | SUPPLIER ECOSYSTEM DEEP DIVE Mapping the Publicly Investable Supply Chain Behind the Defense Autonomous Platform Hawkmont Research | Defense Technology | Autonomous Systems | Supply Chain Intelligence EXECUTIVE SUMMARY Ondas Inc. (NASDAQ: ONDS) has transformed itself from a subscale drone startup into a multi-domain defense prime contractor through six acquisitions totaling over $550 million in transaction value executed in